Global Markets React to Trade Policies, Geopolitical Talks, and Inflation Data
Key Takeaways U.S. Commerce Secretary Howard Lutnick has confirmed that President Trump is offering tech firms a path to avoid […]
[BrokerRatings]Analyst Ratings Update: Biotech and Consumer Retail Lead Strong Buy Trends
Biotech and Consumer Retail sectors lead the charge with multiple stocks recently rated strong buy. Notable upgrades include VRTX, BKNG,
[Earnings]Upcoming Earnings: Key Market Movers and Sector Trends
Wednesday kicks off with major reports, including pharmaceuticals giant Eli Lilly and Company pre-market, alongside several energy companies like ConocoPhillips.
[EconCal]Economic Calendar Outlook: Key Inflation and Fed Events
High-impact inflation data dominates next week. Tuesday, August 12, brings crucial CPI figures (MoM, YoY, Core) at 8:30 AM EST,
Global Markets Eye Trade Extensions, Rising Jobless Claims, and Pharma Breakthroughs
Key Takeaways The US and China are poised to extend their trade truce by another 90 days, aiming to prevent
Stock Market Today: Tech Leads Gains Amid Rate Cut Hopes and Tariff Tensions
As Thursday, August 7th, 2025, unfolds, the U.S. stock market is showing signs of cautious optimism in premarket trading, with
US Labor Market Shows Mixed Signals Amid BoE’s Inflation Battle; Geopolitical Dialogue Continues
Key Takeaways US Initial Jobless Claims for the week ending August 2, 2025, rose to 226,000, surpassing the estimated 222,000
Bank of England Navigates Inflationary Pressures Amidst Economic Slowdown; US Treasury Discusses Fed Chair Search and Tariff Revenue
Key Takeaways The Bank of England (BoE) has cut its benchmark interest rate to 4.0% from 4.25%, a decision reached
Financial Markets React to Key Economic and Corporate Updates
Key Takeaways The Bank of England cut its key interest rate by 25 basis points to 4.0%, marking the fifth
Eli Lilly Soars on Strong Q2 Results and Zepbound Sales, Kenvue Beats EPS Estimates Amid Broader Geopolitical Tensions
Key Takeaways Eli Lilly (LLY) reported robust Q2 2025 earnings, with adjusted EPS of $6.31 significantly exceeding estimates of $3.92